Get our free email newsletter with just one click

Bloomsbury Theatre reopening pushed back to 2018

Bloomsbury Theatre at University College London. Photo: Frankie Roberto Bloomsbury Theatre at University College London. Photo: Frankie Roberto
by -

London’s Bloomsbury Theatre will remain closed until 2018, two years longer than previously planned.

The central London theatre, owned by University College London, has been shut since June 2015, when a scheduled closure was brought forward after asbestos was discovered in the building.

It was initially supposed to be closed for construction work until early this year, in order for the theatre to reopen by the summer, however a statement from UCL confirmed that the 550-seat theatre, known for hosting comedy acts, will now be closed until 2018.

“It has been difficult to predict the length of the closure given the complexity of the work needed to make the site fit for purpose. The reopening was initially scheduled for early 2016 but the extent of the work required now means the earliest potential reopening date for the theatre has been put back to early 2018 to allow for an options appraisal to be undertaken,” the statement said.

The Bloomsbury Theatre Studio, which opened in 2015 and seats 110, will continue to run while the theatre is closed.

The Bloomsbury’s main space was previously closed between July and October 2014 while new seating, a new bar and improved technical equipment were installed.

We need your help…

When you subscribe to The Stage, you’re investing in our journalism. And our journalism is invested in supporting theatre and the performing arts.

The Stage is a family business, operated by the same family since we were founded in 1880. We do not receive government funding. We are not owned by a large corporation. Our editorial is not dictated by ticket sales.

We are fully independent, but this means we rely on revenue from readers to survive.

Help us continue to report on great work across the UK, champion new talent and keep up our investigative journalism that holds the powerful to account. Your subscription helps ensure our journalism can continue.